Non-small cell lung cancer (NSCLC) Clinical Trials in Horsham, PA
As of July 2026, 1 paid clinical trial is recruiting for Non-small cell lung cancer (NSCLC) in Horsham, Pennsylvania. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Horsham
Filter results
1 clinical trial for Non-small cell lung cancer (NSCLC)
·Clear filters·Top Research Study Locations in Horsham
Researchers run research studies in Horsham, PA at 9 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Alliance Cancer Specialists, PC | Breast Cancer, Breast Neoplasms, Esophageal Adenocarcinoma | 3 |
| Abington Medical Specialists | Obesity, Atherosclerotic Cardiovascular Disease, Heart Failure With Mildly Reduced Ejection Fraction | 2 |
| Alliance Cancer Specialists | Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer | 2 |
| Alliance Cancer Specialists (ACS) | DLBCL, Diffuse Large B-Cell Lymphoma | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Hawthorne Health - Horsham | Migraine | 1 |
| Research | Hypertriglyceridemia | 1 |
| USO - Alliance Cancer Specialists, PC | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 1 |
Active & Upcoming Studies in Horsham (2026)
Recruiting trials in Horsham grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (7 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) · Phase 3 · Pfizer
Cardiovascular (4 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Diabetes & metabolic (2 active studies)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Neurology & pain (1 active study)
Common conditions studied in Horsham
- Breast Cancer (2 active studies)
- Obesity (2 active studies)
- Atherosclerotic Cardiovascular Disease (1 active study)
- Atrial Fibrillation (AF) (1 active study)
- Breast Neoplasms (1 active study)
- Carcinoma, Non-Small-Cell Lung (1 active study)
Leading research sponsors in Horsham
- Pfizer
- Amgen
- AstraZeneca
- AbbVie
- Agendia
Frequently asked questions
How many paid clinical trials are currently recruiting in Horsham?
There are approximately 15 recruiting clinical trials in Horsham, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Horsham pay participants?
Most recruiting trials in Horsham compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Horsham?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Horsham?
The most common conditions under active study in Horsham include Breast Cancer (2), Obesity (2), Atherosclerotic Cardiovascular Disease (1), Atrial Fibrillation (AF) (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Horsham?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Horsham on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Horsham?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Horsham?
Recruiting research sites in Horsham include Alliance Cancer Specialists, PC, Abington Medical Specialists, Alliance Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Horsham right now?
The largest active categories in Horsham are Cancer & tumors (7), Cardiovascular (4), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.